Poly(ethylene oxide)-modified poly(ε-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer

International Journal of Pharmaceutics

Volumn 293, Issue 1-2, 2005, Pages 261-270

  Shenoy, Dinesh B ^a   Amiji, Mansoor M ^a  

^a NORTHEASTERN UNIVERSITY   (United States)

Author keywords

Breast cancer; Poly(ethylene oxide) modified poly( caprolactone) nanoparticles; Tamoxifen; Targeted delivery

Indexed keywords

MACROGOL; NANOPARTICLE; POLOXAMER; POLYCAPROLACTONE; POLYMER; SOLVENT; SURFACTANT; TAMOXIFEN; TRITIUM;

ARTICLE; BREAST CARCINOMA; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG ACTIVITY; DRUG ADSORPTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG SCREENING; DRUG TARGETING; ENCAPSULATION; HYDROPHILICITY; MOUSE; MOUSE STRAIN; NONHUMAN; NUDE MOUSE; PARTICLE SIZE; PRIORITY JOURNAL; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; SYSTEMIC CIRCULATION; WETTABILITY; XENOGRAFT;

EID: 15044348714     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.12.010     Document Type: Article

References (41)

1. M.J. Alonso Polymeric nanoparticles: new systems for improving ocular bioavailability of drugs Arch. Soc. Esp. Oftalmol. 76 2001 453 454
2. G. Barratt Colloidal drug carriers: achievements and perspectives Cell. Mol. Life Sci. 60 2003 21 37
3. I. Brigger, C. Dubernet, and P. Couvreur Nanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 2002 631 651
4. J.S. Chawla, and M.M. Amiji Biodegradable poly(epsilon-caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen Int. J. Pharm. 249 2002 127 138
5. J.S. Chawla, and M.M. Amiji Cellular uptake and concentrations of tamoxifen upon administration in poly(epsilon-caprolactone) nanoparticles AAPS PharmSci. 5 2003 E3
6. S.S. Feng, L. Mu, K.Y. Win, and G. Huang Nanoparticles of biodegradable polymers for clinical administration of paclitaxel Curr. Med. Chem. 11 2004 413 424
7. H. Ge, Y. Hu, X. Jiang, D. Cheng, Y. Yuan, H. Bi, and C. Yang Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon- caprolactone) amphiphilic triblock copolymer micelles J. Pharm. Sci. 91 2002 1463 1473
8. R. Gref, M. Luck, P. Quellec, M. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R.H. Muller 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf. B: Biointerfaces 18 2000 301 313
9. A.W. Griffioen, and G. Molema Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation Pharmacol. Rev. 52 2000 237 268
10. K. Kataoka, A. Harada, and Y. Nagasaki Block copolymer micelles for drug delivery: design, characterization and biological significance Adv. Drug Deliv. Rev. 47 2001 113 131
11. C.K. Kim, and S.J. Lim Recent progress in drug delivery systems for anticancer agents Arch. Pharm. Res. 25 2002 229 239
12. J. Kreuter Drug targeting with nanoparticles Eur. J. Drug Metab. Pharmacokinet. 19 1994 253 256
13. J. Kreuter Nanoparticulate systems for brain delivery of drugs Adv. Drug Deliv. Rev. 47 2001 65 81
14. J. Li, K. Caldwell, and N. Rapoport Surface properties of pluronic-coated polymeric colloids Langmuir 10 1994 4475 4482
15. M.L. Matteucci, and D.E. Thrall The role of liposomes in drug delivery and diagnostic imaging: a review Vet. Radiol. Ultrasound 41 2000 100 107
16. S.M. Moghimi, A.C. Hunter, and J.C. Murray Long-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 2001 283 318
17. S.M. Moghimi, and A.C. Hunter Poloxamers and poloxamines in nanoparticle engineering and experimental medicine Trends Biotechnol. 18 2000 412 420
18. S.M. Moghimi Prolonging the circulation time and modifying the body distribution of intravenously injected polystyrene nanospheres by prior intravenous administration of poloxamine-908. A 'hepatic-blockade' event or manipulation of nanosphere surface in vivo? Biochim. Biophys. Acta 1336 1997 1 6
19. S.M. Moghimi, I.S. Muir, L. Illum, S.S. Davis, and V. Kolb-Bachofen Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum Biochim. Biophys. Acta 1179 1993 157 165
20. C. Monfardini, and F.M. Veronese Stabilization of substances in circulation Bioconjugate Chem. 9 1998 418 450
21. R.H. Muller, K. Mader, and S. Gohla Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 2000 161 177
22. S. Oka, T. Kubota, T. Takeuchi, and M. Kitajima Potentiation of antitumor activity of mitomycin C by estradiol: studies of human breast carcinoma xenografts serially transplanted into nude mice J. Surg. Oncol. 61 1996 256 261
23. H. Otsuka, Y. Nagasaki, and K. Kataoka PEGylated nanoparticles for biological and pharmaceutical applications Adv. Drug Deliv. Rev. 55 2003 403 419
24. J. Panyam, and V. Labhasetwar Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv. Drug Deliv. Rev. 55 2003 329 347
25. C.G. Pitt, M.M. Gratzl, G.L. Kimmel, J. Surles, and A. Schindler Aliphatic polyesters. II. The degradation of poly (dl-lactide), poly (epsilon-caprolactone), and their copolymers in vivo Biomaterials 2 1981 215 220
26. C.G. Pitt, T.A. Marks, and A. Schindler Biodegradable drug delivery systems based on aliphatic polyesters: application to contraceptives and narcotic antagonists NIDA Res. Monogr. 28 1981 232 253
27. A. Potineni, D.M. Lynn, R. Langer, and M.M. Amiji Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery J. Contr. Release 86 2003 223 234
28. G.C. Rao, M.S. Kumar, N. Mathivanan, and M.E. Rao Nanosuspensions as the most promising approach in nanoparticulate drug delivery systems Pharmazie 59 2004 5 9
29. P.D. Scholes, A.G. Coombes, L. Illum, S.S. Davis, J.F. Watts, C. Ustariz, M. Vert, and M.C. Davies Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS J Contr. Release 59 1999 261 278
30. V.R. Sinha, K. Bansal, R. Kaushik, R. Kumria, and A. Trehan Poly-epsilon-caprolactone microspheres and nanospheres: an overview Int. J. Pharm. 278 2004 1 23
31. V.R. Sinha, and L. Khosla Bioabsorbable polymers for implantable therapeutic systems Drug Dev. Ind. Pharm. 24 1998 1129 1138
32. M. Smoluchowski Versuch einer mathematischen Theorie der Koagulationskinetik kolloider Lösungen Phys. Chem. (Munich) 92 1917 129 168
33. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski Biodegradable polymeric nanoparticles as drug delivery devices J. Contr. Release 70 2001 1 20
34. P.P. Speiser Nanoparticles and liposomes: a state of the art Meth. Find. Exp. Clin. Pharmacol. 13 1991 337 342
35. S. Stolnik, B. Daudali, A. Arien, J. Whetstone, C.R. Heald, M.C. Garnett, S.S. Davis, and L. Illum The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers Biochim. Biophys. Acta 1514 2001 261 279
36. J.S. Tan, D.E. Butterfield, C.L. Voycheck, K.D. Caldwell, and J.T. Li Surface modification of nanoparticles by PEO/PPO block copolymers to minimize interactions with blood components and prolong blood circulation in rats Biomaterials 14 1993 823 833
37. A.S. Ulrich Biophysical aspects of using liposomes as delivery vehicles Biosci. Rep. 22 2002 129 150
38. S. Vemuri, and C.T. Rhodes Preparation and characterization of liposomes as therapeutic delivery systems: a review Pharm. Acta Helv. 70 1995 95 111
39. S.C. Woodward, P.S. Brewer, F. Moatamed, A. Schindler, and C.G. Pitt The intracellular degradation of poly(epsilon-caprolactone) J. Biomed. Mater. Res. 19 1985 437 444
40. H. Wu, C. Ramachandran, N.D. Weiner, and B.J. Roessler Topical transport of hydrophilic compounds using water-in-oil nanoemulsions Int. J. Pharm. 220 2001 63 75
41. J.A. Zasadzinski, E. Kisak, and C. Evans Complex vesicle-based structures Curr. Opin. Colloid Interf. Sci. 6 2001 85 90